Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Tuesday, April 16, 2024 | Back issues
Courthouse News Service Courthouse News Service

Theranos Investors

A federal judge on Thursday declined to certify a class of Theranos investors who claim they were misled by promises of a breakthrough in blood testing, finding their claims need to be handled individually rather than as a class action.

SAN JOSE, Calif. – A federal judge on Thursday declined to certify a class of Theranos investors who claim they were misled by promises of a breakthrough in blood testing, finding their claims need to be handled individually rather than as a class action.

Categories / Financial, Science

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...